GlassScriptPhysician profile
Julia R Coleman
NPI 1346634276
$1,486.06
in general payments reported to CMS, 2019-2025
9 companies · $747 in 2025
The $747 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $227 · 2024: $513 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,486.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $539.31 | 2024-2025 | Axios, Spyglass Discover |
| Cerus Corporation | $241.44 | 2024 | Intercept Blood System For Platelets |
| Werfen USA LLC | $182.33 | 2025 | |
| Depuy Synthes Sales INC. | $141.03 | 2023 | Matrixrib |
| Grifols USA, LLC | $120.43 | 2024 | Thrombate III |
| Medical Device Business Services, INC. | $85.53 | 2023 | Matrix |
| Hemosonics LLC | $84.13 | 2025 | Quantra Qplus System, Qunatra Qplus System |
| Organogenesis INC. | $77.01 | 2024-2025 | Puraply Wound Matrix |
| Intuitive Surgical, INC. | $14.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.